Hydroxychloroquine, abatacept linked with reduced type 2 diabetes
LONDON – U.S. rheumatoid arthritis patients had a significantly reduced incidence of type 2 diabetes when on treatment with either hydroxychloroquine or abatacept in an analysis of more than 13,000... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 10, 2016 Category: Endocrinology Source Type: news
IV to SC Switch OK for Orencia in RA (CME/CE)
(MedPage Today) -- Going on vacation and don't want to bring meds along? (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 23, 2016 Category: Geriatrics Source Type: news
Monotherapy an Option in RA With Orencia (CME/CE)
(MedPage Today) -- Suitable for patients who can't tolerate methotrexate (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 14, 2016 Category: Geriatrics Source Type: news
Orencia: Try Again in Lupus? (CME/CE)
(MedPage Today) -- Benefits seen for articular symptoms (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 31, 2016 Category: Primary Care Source Type: news
Sustaining Remission After RA Therapy Ends Sustaining Remission After RA Therapy Ends
Dr Deane discusses results from a randomized trial evaluating maintenance of remission after rapid withdrawal of abatacept and methotrexate--alone or in combination. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2016 Category: Consumer Health News Tags: Rheumatology Viewpoint Source Type: news
Antibodies Predict RA Response to Orencia (CME/CE)
(MedPage Today) -- Patients seropositive for rheumatoid factor or ACPA less likely to stop abatacept (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 8, 2016 Category: Geriatrics Source Type: news
Review Shows Varying Safety of Rheum Biologics (CME/CE)
(MedPage Today) -- Results generally favor Orencia and others over Remicade in autoimmune disorders (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - December 23, 2015 Category: Geriatrics Source Type: news
Orencia Does Not Ruin Pneumonia Vax Efficacy (CME/CE)
(MedPage Today) -- Abatacept suppresses immune response a bit, but vaccine should still work (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 18, 2015 Category: Rheumatology Source Type: news
Orencia Safe in RA, Even With HBV (CME/CE)
(MedPage Today) -- An Italian study found no cases of viral reactivation over 2 years (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - November 20, 2015 Category: Geriatrics Source Type: news
Antibodies and RA Treatment: Is There a Link? (CME/CE)
(MedPage Today) -- Anti-citrullinated protein antibodies levels predicted response with Orencia, but not Humira (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - September 15, 2015 Category: Geriatrics Source Type: news
Orencia, Actemra Comparable for RA Treatment (CME/CE)
(MedPage Today) -- Similar efficacy, but baseline predictors of response differed (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 11, 2015 Category: Geriatrics Source Type: news
Abatacept Might Be First-Ever Treatment for Rare Immune DeficiencyAbatacept Might Be First-Ever Treatment for Rare Immune Deficiency
Some devastating aspects of common variable immune deficiency are a result of a defect in trafficking of the immune down-regulator CTLA4, which can be overcome by treatment with abatacept. Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 4, 2015 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news
Abatacept Safety, Efficacy Maintained in JIA (CME/CE)
(MedPage Today) -- Phase III study reports reduction of adverse events with long-term use (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 29, 2015 Category: Geriatrics Source Type: news
Rituxan Cost-Effective Choice After TFN Inhibitors Fail (CME/CE)
(MedPage Today) -- For RA patients, rituximab is equivalent to IV abatacept in safety and efficacy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 4, 2015 Category: Primary Care Source Type: news
RA: Infection Risk Lower With Enbrel or Orencia (CME/CE)
(MedPage Today) -- Studies are needed to balance harms and benefits of different biologics in individual patients. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - May 26, 2015 Category: Consumer Health News Source Type: news
